Kyle Jenne

Insider Reports History

Entity
Individual
Location
C/O Akcea Therapeutics, Inc., 22 Boston Wharf Road, 9 Th Floor, Boston, MA
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Kyle Jenne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Jenne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IONIS PHARMACEUTICALS INC EVP, Chf GL Pdt Str Ofcr Common Stock 1.99K $68.5K $34.43 Feb 26, 2024 Direct
IONIS PHARMACEUTICALS INC EVP, Chf GL Pdt Str Ofcr Non-Qualified Stock Option (right to buy) 65.2K Feb 26, 2024 Direct

Insider Reports Filed by Kyle Jenne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IONS IONIS PHARMACEUTICALS INC Feb 26, 2024 1 $0 4 Mar 13, 2024 EVP, Chf GL Pdt Str Ofcr
IONS IONIS PHARMACEUTICALS INC Feb 26, 2024 0 $0 3 Mar 13, 2024 EVP, Chf GL Pdt Str Ofcr